OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Single Kit) +1 more— 510(k) K250213

Substantially Equivalent

Stryker Instruments

FDA 510(k) clearance K250213 for OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Single Kit) +1 more, Substantially Equivalent on 2025-05-15. Applicant: Stryker Instruments. Device class: 2.

Clearance details

Device name as filed
OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Single Kit); OptaBlate BVN Intraosseous Nerve Ablation System (10mm Probe Dual Kit)
Applicant
Stryker Instruments
Product code
Code GXI
Device class
Class 2
Regulation
21 CFR 882.4725
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Portage, MI, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code GXI

view all

More clearances from Stryker Instruments

view all

Adverse events under product code GXI

product code GXI
Death
3
Injury
171
Total
174

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.